Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Considerations in the development of generic disease therapies for multiple sclerosis.
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
[The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis].
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Neurotherapeutic Strategies for Multiple Sclerosis.
Environmental factors in autoimmune diseases and their role in multiple sclerosis.
Is pruritus an indicator of aquaporin-positive neuromyelitis optica?
Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis.
Infantile metachromatic leukodystrophy in an 18 month old girl.
How human IgGs against DNA recognize oligonucleotides and DNA.
Multiple sclerosis and vitamin D: an update.
Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.
Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.
The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen.
Autonomic function and brain volume.
Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
Osmotic demyelination syndrome after slow sodium administration in a hyponatremic patient with concurrent hypokalemia.
Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization.
Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.
Multiple sclerosis in Brazil: A systematic review.
The best basic science paper on multiple sclerosis in 2012: Commentary.
Pages
« first
‹ previous
…
696
697
698
699
700
701
702
703
704
…
next ›
last »